| Laboratory findings | |
| Cryocrit, %, mean ± SD | 9.45 ± 7.15 |
| Cryoglobulin immunochemical types, no. of patients (%) | |
| II | 13 (65) |
| III | 7 (35) |
| γ-globulin level (normal, 0.7-1.6 g/dL) | 1.2 ± 0.59 g/dL |
| IgM value (normal, 40-230 mg/dL, mean ± SD) | 472.87 ± 308.9 mg/dL |
| RF activity (normal, 20 IU/mL or less, mean ± SD) | 528.31 ± 1095.7 IU/mL |
| Complement fractions | |
| C3 (normal, 80-140 mg/dL) | 113.93 ± 31.2 mg/dL |
| C4 (normal, 15-48 mg/dL) | 5.43 ± 3.8 mg/dL |
| Virologic findings | |
| Anti-HCV antibodies | |
| Positive, no. of patients (%) | 20 (100) |
| Titer, OD sample/OD cutoff | 80.55 ± 47.8 |
| HCV RNA | |
| Positive, no. of patients (%) | 20 (100) |
| Titer, IU/mL | 542 718 ± 354 439 IU/mL |
| HCV genotype, no. of patients (%) | |
| Type 1b | 11 (55) |
| Type 2a/2c | 9 (45) |
| Histologic findings, no. of patients (%) | |
| Chronic active hepatitis | 19 (95) |
| Cirrhosis | 1 (5) |
| Laboratory findings | |
| Cryocrit, %, mean ± SD | 9.45 ± 7.15 |
| Cryoglobulin immunochemical types, no. of patients (%) | |
| II | 13 (65) |
| III | 7 (35) |
| γ-globulin level (normal, 0.7-1.6 g/dL) | 1.2 ± 0.59 g/dL |
| IgM value (normal, 40-230 mg/dL, mean ± SD) | 472.87 ± 308.9 mg/dL |
| RF activity (normal, 20 IU/mL or less, mean ± SD) | 528.31 ± 1095.7 IU/mL |
| Complement fractions | |
| C3 (normal, 80-140 mg/dL) | 113.93 ± 31.2 mg/dL |
| C4 (normal, 15-48 mg/dL) | 5.43 ± 3.8 mg/dL |
| Virologic findings | |
| Anti-HCV antibodies | |
| Positive, no. of patients (%) | 20 (100) |
| Titer, OD sample/OD cutoff | 80.55 ± 47.8 |
| HCV RNA | |
| Positive, no. of patients (%) | 20 (100) |
| Titer, IU/mL | 542 718 ± 354 439 IU/mL |
| HCV genotype, no. of patients (%) | |
| Type 1b | 11 (55) |
| Type 2a/2c | 9 (45) |
| Histologic findings, no. of patients (%) | |
| Chronic active hepatitis | 19 (95) |
| Cirrhosis | 1 (5) |